Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Omega Pharma Is Potential Buyer for GSK OTC Brands, L’Echo Says

March 1 (Bloomberg) -- Omega Pharma NV may bid for European over-the-counter medicine brands that have been put up for sale by GlaxoSmithKline Plc, L’Echo reported, without saying where it got the information.

The buyer is expected to pay more than 250 million euros ($333.4 million) for the brands, the newspaper said.

Link to Company News: {OME BB <Equity> CN <GO>} Link to Company News: {GSK LN <Equity> CN <GO>}

To contact the reporter on this story: Jim Brunsden in Brussels at jbrunsden@bloomberg.net

To contact the editor responsible for this story Anthony Aarons at aaarons@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.